Tosoh Bioscience is proud to announce the 30th anniversary of its European subsidiary as a premier provider of chromatographic solutions for the industry. This jubilee stands for three decades of expertise, exceptional products and services in biochromatography applied in analytics and downstream processing.

Tosoh Bioscience GmbH was established in July 1989 in Stuttgart, Germany under the company name TosoHaas GmbH (a joint venture between Tosoh Corporation, Japan and Rohm and Haas, US) with the aim of better serving European customers in the life sciences and pharmaceutical industries with TSKgel® analytical HPLC columns and TOYOPEARL® separation media. Alongside the successful development of biotechnology, the company experienced continuous growth. Over the years, Tosoh Bioscience has become a leading solution provider with a competent technical support team and sales & marketing specialists. The year 2015 marked another important milestone in the history of Tosoh Bioscience in Europe with the centralization of offices, presentation and laboratory facilities in Griesheim near Darmstadt.

Recently, Dr Christian Rohrer has been appointed Sales and Marketing Director. He has strong confidence that Tosoh Bioscience is well prepared for the years to come: “Some upcoming transformations in our industries have not yet been identified. Therefore, flexibility and an ability to be able to react to the unexpected is important for global companies to guarantee resilience in the future. One crucial aspect of this preparedness is how we will be able to understand and offer solutions to our customers. I am amazed by how dedicated and passionate everybody at Tosoh is. Customer centricity comes as a natural behaviour and is part of the DNA of the company.”

The dedication of Tosoh Corporation to the Bioscience business is mandatory for the long-lasting success of Tosoh Bioscience.

Masanobu Kasai, Senior General Manager of the Bioscience Division at Tosoh Corporation summarizes its vision for Tosoh Bioscience: “Our customers are using our products to analyze and make innovative products for the biopharmaceutical industry that are contributing to our global society to provide one of UNO’s Sustainable Development Goals – ‘Good health and well-being for people’. We as Tosoh Corporation will continue to support Tosoh Bioscience to keep providing our customers with the best solutions for this purpose.”

Over the years, many successful product introductions broadened the portfolio. Besides the successful TOYOPEARL HIC and ion exchange media, Tosoh introduced innovative products such as mixed-mode, antibody affinity, and salt-tolerant ion exchange resins with outstanding binding capacities and the renowned TOYOPEARL robustness. Latest (U)HPLC column innovations are related to antibody characterization by affinity and UHPLC solutions for SEC.

Tosoh has a long and successful history in manufacturing instruments for gel permeation chromatography (GPC) for the Asian market, and in 2008, Tosoh Bioscience started to market the latest generation of GPC instruments in Europe. The GPC line encompasses the compact EcoSEC® standard GPC system and the EcoSEC-HT, a high-temperature GPC system for analysis up to 220°C. The year 2020 will see further exciting moments in the history of Tosoh Bioscience GmbH with the launch of the next generation GPC system, EcoSEC Elite, and of a revolutionary Multi-Angle Light Scattering Detector, LenS3™.